glutathione superflow agarose Nickel NTA Chelating 4 binding enzymes Affinity chromatography media, glutathione superflow
Description
Results may vary from person to person
Nano-based approved pharmaceuticals for cancer treatment: present and future challenges
showed that the transcription level of Wnt3a in GMSCs was high, and the CD39-specific inhibitor POM-1 inhibited the expression of Wnt3a and reduced the level of -catenin, ultimately leading to loss of the osteogenic ability of GMSCs
Immunopathogenesis of IBD: Current state of the art
